Header Logo

Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma.

Friend R, Bhutani M, Voorhees PM, Usmani SZ. Clinical potential of SLAMF7 antibodies - focus on elotuzumab in multiple myeloma. Drug Des Devel Ther. 2017; 11:893-900.

View in: PubMed